Brief: Medicenna Therapeutics QTRLY Loss Per Share $0.07
13/02/2020 12:54
Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA REPORTS THIRD QUARTER FISCAL 2020 FINANCIAL
RESULTS
* QTRLY LOSS PER SHARE $0.07
Source text for Eikon: ID:nCNWlDTgKa
Further company coverage: MDNA.TO
Recent news on Medicenna Therapeutics
See all newsCanada's Medicenna Q1 net loss slightly widens on smaller fair value gain
Brief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer